Editorial
Copyright ©The Author(s) 2022.
World J Gastroenterol. Nov 21, 2022; 28(43): 6078-6089
Published online Nov 21, 2022. doi: 10.3748/wjg.v28.i43.6078
Table 1 Kyoto classification score
Endoscopic findingsKyoto score
0
1
2
Atrophy1None, C1C2, C3O1-O3
Intestinal metaplasiaNoneAntrumCorpus and antrum
Enlarged foldsAbsencePresence-
NodularityAbsencePresence-
Diffuse rednessNoneMild with RACSevere without RAC
Table 2 Diagnostic performance of Kyoto classification for Helicobacter pylori infection

Ref.
Country
No. of patients
Sensitivity
Specificity
Accuracy
Non-infection
RACGarcés-Durán et al[22], 2019Spain14010049.065.0
Yoshii et al[17], 2020Japan48589.179.885.6
Zhao et al[19], 2020China58362.473.769.3
Ebigbo et al[23], 2021Germany20080.857.4-
Fiuza et al[20], 2021Brazil18770.787.274.9
Glover et al[24], 2021UK15378.464.375.8
Yuan et al[21], 2021China16551.496.776.4
Hirai et al[18], 2021Japan176193.283.290.6
Current infection
AtrophyToyoshima et al[27], 2018Japan13682.685.885.3
Zhao et al[19], 2020China58354.961.158.5
Ebigbo et al[23], 2021Germany20080.469.7-
Intestinal metaplasiaToyoshima et al[27], 2018Japan13639.195.686.0
Enlarged foldsToyoshima et al[27], 2018Japan13617.499.185.3
Yoshii et al[17], 2020Japan49423.196.685.0
NodularityToyoshima et al[27], 2018Japan1368.710084.6
Yoshii et al[17], 2020Japan4946.498.383.8
Toyoshima et al[28], 2020Japan26533.399.689.1
Fiuza et al[20], 2021Brazil18710.698.676.5
Diffuse rednessToyoshima et al[27], 2018Japan13652.293.886.8
Yoshii et al[17], 2020Japan48560.094.789.7
Zhao et al[19], 2020China58320.397.665.0
Fiuza et al[20], 2021Brazil18780.973.675.4
Total Kyoto scoreToyoshima et al[27], 20181Japan13678.392.089.7
Sumi et al[30], 20222Japan56198.798.498.6
Table 3 Gastric cancer incidence based on endoscopic atrophy
Ref.PopulationNo. of subjectsNo. of cancersDuration, yrGastric cancer incidence, %/yr
Atrophy (mild)
Atrophy (moderate)
Atrophy (severe)
Shichijo et al[39], 20161,2Post eradication573216.2 ± 4.80.070.341.60
Kaji et al[40], 20193Screening12941633.7 ± 0.80.100.160.31
Post eradication2571203.7 ± 0.80.060.120.42
Take et al[41], 20201Post eradication2737687.1 ± 5.40.150.290.67
Table 4 Odds ratio for histological subtype of gastric cancer based on the Kyoto classification

Ref.
H. pylori status
No. of subjects
No. of GC
No. of diffuse-type GC
No. of intestinal-type GC
OR for GC
OR for diffuse-type GC
OR for intestinal-type GC
AtrophySekikawa et al[43], 2016Current, past, and no infection1823293267.41
Toyoshima et al[44], 2021Current infection49913239932.82.36.2
Kawamura et al[45], 2022Current, past, and no infection38011519962.51
Intestinal metaplasiaShichijo et al[48], 2017Current, past, and no infection339210722850.22
Toyoshima et al[44], 2021Current infection49913239931.61.7
Enlarged foldsNishibayashi et al[81], 2003Current infection27613569665.0
Toyoshima et al[44], 2021Current infection49913239930.5
NodularityNishikawa et al[53], 2018Current infection6742591610.0
Toyoshima et al[44], 2021Current infection49913239930.50.3
RACKawamura et al[45], 2022Current, past, and no infection38011519960.23
Total Kyoto scoreToyoshima et al[44], 2021Current infection49913239931.61.31.7
Lin et al[61], 2022Current, past, and no infection184837--1.5
Table 5 Odds ratio of gastric cancer after Helicobacter pylori eradication based on the Kyoto classification

Ref.
No. of subjects
No. of GC
Odds ratio
AtrophyYan et al[57], 202119611328.11
Map-like rednessMoribata et al[55], 201612222235.3
Majima et al[56], 20191941092.1
Yan et al[57], 202119611321.8
RACMajima et al[56], 20191941090.4
Ohno et al[58], 2020162430.3